CDC-II;2-ETHOXY-1-[[2'-(1-ETHYL-1-H-TETRAZOL-5-YL)-BIPHENYL-4-YL]-METHYL]-1-H-BENZIMIDAZOLE-7-CARBOXYLIC_ACID_ETHYLESTER
Compound with spectra: 1 NMR
![CDC-II;2-ETHOXY-1-[[2'-(1-ETHYL-1-H-TETRAZOL-5-YL)-BIPHENYL-4-YL]-METHYL]-1-H-BENZIMIDAZOLE-7-CARBOXYLIC_ACID_ETHYLESTER](/api/compound/6QbFJydBk8V.png?ph=true&h=300&w=458 "CDC-II;2-ETHOXY-1-[[2'-(1-ETHYL-1-H-TETRAZOL-5-YL)-BIPHENYL-4-YL]-METHYL]-1-H-BENZIMIDAZOLE-7-CARBOXYLIC_ACID_ETHYLESTER")
| SpectraBase Compound ID | 6QbFJydBk8V |
|---|---|
| InChI | InChI=1S/C28H28N6O3/c1-4-34-26(30-31-32-34)22-11-8-7-10-21(22)20-16-14-19(15-17-20)18-33-25-23(27(35)36-5-2)12-9-13-24(25)29-28(33)37-6-3/h7-17H,4-6,18H2,1-3H3 |
| InChIKey | XIDKHXGGUWNFTH-UHFFFAOYSA-N |
| Mol Weight | 496.57 g/mol |
| Molecular Formula | C28H28N6O3 |
| Exact Mass | 496.222289 g/mol |
| Copyright | Copyright © 2016-2025 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
Azilsartan-M (HO-) MS2
FENOP-NME2;(1R,2R,4S)-2-(4-N,N-DIMETHYLPYRIDINE-2-YL)-1,3,3-TRIMETHYL-BICYCLO-[2.2.1]-HEPT-2-YL-DIPHENYLPHOSPHINITE
beta-D-glucopyranoside, 4-ethyl-5-phenyl-4H-1,2,4-triazol-3-yl 2-(acetylamino)-2-deoxy-1-thio-, 3,4,6-triacetate
3-(2-furanyl)-[1,2,4]triazolo[4,3-f]phenanthridine
JKLZQDBRZGGGDW-DZGDQSPQSA-N
12,19-Dimethoxy-14-pyperidylpodocarpa-8,11,13-triene
PRIONOID_B;12-HYDROXY-13-ISOPROPYL-5-METHYL-2-(2-METHYL-PROPENYL)_BENZO-[DE]-CHROMEN-1-ONE
1-(3-C-AZIDO-3-C-METHANSULFONYLOXYMETHYL-5-O-PARA-METHOXYPHENYL-ALPHA-D-ARABINOFURANOSYL)-THYMINE
1-(3-C-AZIDO-3-C-METHANSULFONYLOXYMETHYL-5-O-PARA-METHOXYPHENYL-BETA-D-ARABINOFURANOSYL)-THYMINE
(.+/-.)-mahanine, acetate
| Title | Journal or Book | Year |
|---|---|---|
| Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR | Journal of Pharmaceutical and Biomedical Analysis | 2011 |